GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 6.705
EU - Europa 3.181
AS - Asia 1.204
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
AF - Africa 5
OC - Oceania 4
Totale 11.115
Nazione #
US - Stati Uniti d'America 6.616
IT - Italia 1.000
DE - Germania 510
CN - Cina 501
SE - Svezia 430
SG - Singapore 419
IE - Irlanda 344
RU - Federazione Russa 252
UA - Ucraina 184
GB - Regno Unito 131
HK - Hong Kong 126
CA - Canada 86
FI - Finlandia 67
VN - Vietnam 60
DK - Danimarca 58
AT - Austria 57
FR - Francia 43
IN - India 36
BE - Belgio 24
ID - Indonesia 21
NL - Olanda 18
TR - Turchia 16
CZ - Repubblica Ceca 15
BG - Bulgaria 14
CH - Svizzera 8
IR - Iran 8
JP - Giappone 8
PL - Polonia 6
RO - Romania 6
ES - Italia 5
EU - Europa 5
KR - Corea 5
AU - Australia 4
CL - Cile 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HU - Ungheria 2
MX - Messico 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 11.115
Città #
Ann Arbor 1.819
Fairfield 557
Woodbridge 461
Chandler 444
Wilmington 395
Houston 390
Singapore 359
Dublin 332
Ashburn 323
Milan 315
Frankfurt am Main 304
Dearborn 248
Seattle 229
Jacksonville 199
Cambridge 177
New York 174
Santa Clara 155
Princeton 134
Hong Kong 115
Lissone 104
Shanghai 97
Nanjing 76
Lawrence 61
Vienna 57
Altamura 52
Falls Church 43
San Diego 42
Beijing 40
Guangzhou 39
Fremont 38
Helsinki 34
Lachine 30
Boardman 28
Nanchang 27
Shenyang 27
Dong Ket 26
London 25
Jinan 24
Brussels 22
Jakarta 21
Ottawa 21
Andover 18
Hebei 17
Segrate 16
Genoa 15
Kunming 15
Brno 14
Toronto 14
Bari 13
Monza 13
Munich 13
Edmonton 12
Plovdiv 12
Pune 12
Tianjin 12
Dallas 10
Florence 9
Jiaxing 9
Changsha 8
Leawood 8
Ningbo 8
Norwalk 8
Nürnberg 8
Biella 7
Huizen 7
Pioltello 7
Rome 7
San Mateo 7
Chicago 6
Cornate d'Adda 6
Detroit 6
Kiev 6
Kocaeli 6
Lanzhou 6
Lecco 6
Montréal 6
Redmond 6
Taizhou 6
Turin 6
Udine 6
Zhengzhou 6
Alessandria 5
Como 5
Desio 5
Gorgonzola 5
Hangzhou 5
Hefei 5
Los Angeles 5
Mountain View 5
Napoli 5
Orta di Atella 5
Paris 5
Torino 5
Washington 5
Bonndorf 4
Carate Brianza 4
Catania 4
Daejeon 4
Kilburn 4
Lausanne 4
Totale 8.530
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 380
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 322
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 319
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 309
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 288
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 270
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 246
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 242
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 241
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 232
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 229
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 228
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 224
Motion management in PET/CT: Technological solutions 220
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 217
Respiratory motion management in PET/CT: applications and clinical usefulness 215
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 210
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 208
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 203
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 201
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 197
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 196
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 195
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 190
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 188
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 188
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 186
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 182
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 182
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 178
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 176
Imaging of lung inflammation during severe influenza A: H1N1 175
Focal bone lesions in hiv-positive patient treated with tenofovir 175
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 170
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 169
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 163
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 161
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 157
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 156
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 155
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 149
A case of Melas (A3243G) on chronic dichloroacetate treatment 147
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 144
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 143
Tidal changes on CT and progression of ARDS 141
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 136
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 130
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 129
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 129
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 127
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 124
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 123
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 118
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 116
Respiratory Gating and the performance of PET/CT in pulmonary lesions 101
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 100
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 97
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 90
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 87
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 85
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 79
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 73
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 73
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 66
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 62
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 59
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 49
Current status of FDG-PET/CT in staging of adult lymphoma 47
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 46
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 43
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 38
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 29
Totale 11.623
Categoria #
all - tutte 39.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.011 0 0 0 0 0 0 312 194 214 126 124 41
2020/20212.081 76 82 203 229 172 195 178 231 171 199 150 195
2021/20221.250 140 159 142 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20251.156 145 338 207 119 196 150 1 0 0 0 0 0
Totale 11.623